JUST IN: New preliminary study suggests Pfizer-BioNTech vaccine may only partially protect against omicron variant, but that a booster offers greater protection.
Share to TwitterResults from an initial laboratory study show that the omicron variant can partially dodge protection from two doses of the COVID-19 vaccine developed by American pharmaceutical company Pfizer and its German partner BioNTech.
The study was conducted in a laboratory by exposing a vaccinated individual's blood to omicron to see whether the vaccine would neutralise the variant. Some of the participants included in the study had received two doses of the vaccine, while others had gotten a third booster dose.A healthcare worker receives a Pfizer COVID-19 booster shot at Jackson Memorial Hospital, Oct. 5, 2021, in Miami.
The study measured antibody levels, which are only one part of a person's overall protection. The exact percentage of vaccine efficacy against the omicron variant remains unclear.Share to TwitterDr. Anthony Fauci on Tuesday told news agency Agence France-Presse that the omicron variant is "almost certainly" not more severe than delta.
He also reiterated that it would take at least several more weeks to understand key questions surrounding omicron's severity.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer, BioNTech say initial lab study showed 3 doses of COVID-19 vaccine neutralized omicron variantPfizer Inc. undefined and BioNTech SE undefined said results from an 'initial laboratory study' showed that their COVID-19 vaccine neutralized the omicron...
Read more »
Pfizer, BioNTech vaccine neutralises Omicron with three shotsBioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine in March 2022 if needed.
Read more »
Omicron variant partly evades Pfizer vaccine's protection, study showsThe Omicron coronavirus variant partly escapes the protection offered by the Pfizer vaccine, but people who have been previously infected and then vaccinated are likely to be well protected, researchers working in South Africa reported Tuesday.
Read more »
Omicron significantly reduces Covid antibody protection in small study of Pfizer vaccine recipients
Read more »
Pfizer vaccine 'partially protective' against OmicronOmicron variant of the coronavirus can partially evade the protection from Pfizer and partner BioNTech's vaccine, new research shows
Read more »
Pfizer CEO says omicron appears milder but spreads faster and could lead to more Covid mutations
Read more »